Clinical Trial Update: Study to Evaluate the Digestive Tolerability of ART44 Versus ART®50 in Patients With Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the digestive tolerability of ART44 versus ART50 in patients with knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• ART44
• ART50

Snippet

Sponsor: Laboratoires NEGMA | Conditions: Knee Osteoarthritis | Phase 3 | Status: UNKNOWN